James Garbutt

Psychiatry & Neurology / Psychiatry

Credentials: · ·

History

Efficacy and Safety of the Melanocortin Activator Bupropion in Treating Binge Drinking
National Institute on Alcohol Abuse and Alcoholism · R21
Contact PI · $399K · Univ of North Carolina Chapel Hill
2017–2019
Intranasal Oxytocin Treatment for Alcohol Use Disorders: A Randomized, Placebo-Controlled Trial
National Institute on Alcohol Abuse and Alcoholism · R01
PI · $409.4K · Univ of North Carolina Chapel Hill
2018–2019
Efficacy and Safety of High-Dose Baclofen for Alcohol Dependence
National Institute on Alcohol Abuse and Alcoholism · R01
Contact PI · $1.1M · Univ of North Carolina Chapel Hill
2013–2018
Oxytocin Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial
National Institute on Alcohol Abuse and Alcoholism · R21
PI · $393.6K · Univ of North Carolina Chapel Hill
2014–2017

Buproprion for Binge Drinking
Principal investigator · Completed · Phase 2
University of North Carolina, Chapel Hill
2017–2019
An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
Principal investigator · Completed · Phase 2
University of North Carolina, Chapel Hill
2016–2017
Oxytocin Treatment of Opioid Dependence
Principal investigator · Completed · Phase 1, Phase 2
University of North Carolina, Chapel Hill
2016
Oxytocin Treatment of Alcohol Dependence
Principal investigator · Completed · Phase 2
University of North Carolina, Chapel Hill
2015–2016